Gauvin K, Allain V, Bouhamdani N, Williams C, Saheb Y, Savoie C
Cancer Med. 2025; 14(3):e70640.
PMID: 39907309
PMC: 11795414.
DOI: 10.1002/cam4.70640.
Yuen J, Zhou S, Caeser R, Venkatramani M, Bte Ishak D, Li S
Eur J Hum Genet. 2025; 33(3):289-296.
PMID: 39843919
PMC: 11894078.
DOI: 10.1038/s41431-025-01785-1.
Sae-Lim C, Jo S, Park S, Kweon T, Lee J, Lee Y
J Breast Cancer. 2025; 27(6):372-382.
PMID: 39761944
PMC: 11710906.
DOI: 10.4048/jbc.2024.0146.
Mesaric V, Blatnik A, Drusany Staric K, Strojnik K, Stegel V, Hotujec S
Hum Genomics. 2024; 18(1):137.
PMID: 39696405
PMC: 11657269.
DOI: 10.1186/s40246-024-00706-5.
Vandermeulen M, Khaiwal S, Rubio G, Liti G, Cullen P
iScience. 2024; 27(10):110860.
PMID: 39381740
PMC: 11460476.
DOI: 10.1016/j.isci.2024.110860.
Potential Role of Glyphosate, Glyphosate-Based Herbicides, and AMPA in Breast Cancer Development: A Review of Human and Human Cell-Based Studies.
Schluter H, Bariami H, Park H
Int J Environ Res Public Health. 2024; 21(8).
PMID: 39200696
PMC: 11354939.
DOI: 10.3390/ijerph21081087.
Possible link between familial susceptibility to cancer and the level of oxidative stress in thyroid cancer patients.
Javakhishvili I, Mardaleishvili K, Buleishvili M, Mantskava M, Chkhikvishvili I, Kalmakhelidze S
Hered Cancer Clin Pract. 2024; 22(1):15.
PMID: 39180118
PMC: 11342469.
DOI: 10.1186/s13053-024-00287-3.
Phenotypes of carriers of two mutated alleles in major cancer susceptibility genes.
Laitman Y, Niskakoski A, Bernstein-Molho R, Koskinen L, Rabina D, Koskenvuo J
Breast Cancer Res Treat. 2024; 208(3):589-595.
PMID: 39102164
PMC: 11522137.
DOI: 10.1007/s10549-024-07454-z.
Multilocus inherited neoplasia allele syndrome: report of uncommon combinations between and genes.
Ubilla R, Zeppelin M, Martin F
Ecancermedicalscience. 2024; 18:1701.
PMID: 39021548
PMC: 11254408.
DOI: 10.3332/ecancer.2024.1701.
Effect of Variations on the Clear Cell Renal Carcinoma Risk and Overall Survival.
Andrzejczak A, Malkiewicz B, Tupikowski K, Ptaszkowski K, Szydelko T, Karabon L
Int J Mol Sci. 2024; 25(13).
PMID: 38999968
PMC: 11241222.
DOI: 10.3390/ijms25136860.
X-ray crystal structure of a designed rigidified imaging scaffold in the ligand-free conformation.
Agdanowski M, Castells-Graells R, Sawaya M, Cascio D, Yeates T, Arbing M
Acta Crystallogr F Struct Biol Commun. 2024; 80(Pt 5):107-115.
PMID: 38767964
PMC: 11134730.
DOI: 10.1107/S2053230X2400414X.
Possible Markers for Distinguishing benign and Malignant Thyroid Tumors and Predicting Malignancy in Patients with Genetic Predisposition to Cancer.
Javakhishvili I, Mardaleishvili K, Mantskava M, Shekiladze E, Tortladze M, Kalmakhelidze S
Asian Pac J Cancer Prev. 2024; 25(2):465-472.
PMID: 38415532
PMC: 11077121.
DOI: 10.31557/APJCP.2024.25.2.465.
Loss of symbiotic and increase of virulent bacteria through microbial networks in Lynch syndrome colon carcinogenesis.
Sadeghi M, Mestivier D, Carbonnelle E, Benamouzig R, Khazaie K, Sobhani I
Front Oncol. 2024; 13:1313735.
PMID: 38375206
PMC: 10876293.
DOI: 10.3389/fonc.2023.1313735.
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.
Cheng S, Su Y, Chiang N, Wang C, Chao Y, Huang C
J Biomed Sci. 2024; 31(1):21.
PMID: 38350919
PMC: 10865564.
DOI: 10.1186/s12929-024-01008-7.
Increased risk of contralateral breast cancer for BRCA1/2 wild-type, high-risk Korean breast cancer patients: a retrospective cohort study.
Kang E, Jung J, Lim C, Kim H, Lee H, Han W
Breast Cancer Res. 2024; 26(1):14.
PMID: 38254240
PMC: 10801954.
DOI: 10.1186/s13058-024-01769-x.
Synchronous and Metachronous Breast and Ovarian Cancers: Experience from a Single Tertiary Care Cancer Centre in India.
Joshi S, Murali-Nanavati S, Shylasree T, Hawaldar R, Tripathi S, Sahay A
Indian J Surg Oncol. 2024; 14(4):809-821.
PMID: 38187845
PMC: 10767083.
DOI: 10.1007/s13193-023-01749-1.
Pathogenic germline variants in patients with breast cancer: conversations across generations, practices and patients' attitude.
Abdel-Razeq H, Mustafa R, Abdel-Razeq S, Abu-Fares H, Al Masri S, Damsees R
Front Genet. 2023; 14:1194075.
PMID: 37920853
PMC: 10619647.
DOI: 10.3389/fgene.2023.1194075.
Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.
Ofverholm A, Torngren T, Rosen A, Arver B, Einbeigi Z, Haraldsson K
BMC Cancer. 2023; 23(1):738.
PMID: 37563628
PMC: 10413543.
DOI: 10.1186/s12885-023-11229-y.
Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel.
AlHarbi M, Mobark N, AlJabarat W, ElBardis H, Alsolme E, Hamdan A
Oncotarget. 2023; 14:580-594.
PMID: 37306523
PMC: 10259259.
DOI: 10.18632/oncotarget.28457.
Comparing telemedicine and in-person gastrointestinal cancer genetic appointment outcomes during the COVID-19 pandemic.
Williams S, Ebrahimzadeh J, Clay D, Constantino G, Heiman J, Wangensteen K
Hered Cancer Clin Pract. 2023; 21(1):6.
PMID: 37158974
PMC: 10165576.
DOI: 10.1186/s13053-023-00250-8.
